# The ED95 Dose of Sugammadex to Reverse Rocuronium-Induced Deep Neuromuscular Block Back to Shallow Neuromuscular Block

> **NCT05841316** · — · UNKNOWN · sponsor: **Ankara University** · enrollment: 40 (estimated)

## Conditions studied

- Deep Neuromuscular Blockade
- Anesthesia, General

## Interventions

- **DRUG:** Sugammadex

## Key facts

- **NCT ID:** NCT05841316
- **Lead sponsor:** Ankara University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-10
- **Primary completion:** 2023-12
- **Final completion:** 2023-12-01
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2023-08-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05841316

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05841316, "The ED95 Dose of Sugammadex to Reverse Rocuronium-Induced Deep Neuromuscular Block Back to Shallow Neuromuscular Block". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT05841316. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*